These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
239 related articles for article (PubMed ID: 32192399)
1. Successful treatment of refractory lupus erythematosus profundus with the interleukin-6 antagonist tocilizumab: a case report. Elolemy G; Al Rashidi A; Dehrab A; Almathkouri A; Varghese A; Chikhly M; Alkhawaja F Lupus; 2020 Jun; 29(7):791-794. PubMed ID: 32192399 [TBL] [Abstract][Full Text] [Related]
2. Generalized lupus erythematosus profundus in a patient with genetic partial deficiency of C4. Nousari HC; Kimyai-Asadi A; Provost TT J Am Acad Dermatol; 1999 Aug; 41(2 Pt 2):362-4. PubMed ID: 10426934 [TBL] [Abstract][Full Text] [Related]
3. Rituximab for the treatment of lupus erythematosus panniculitis. Moreno-Suárez F; Pulpillo-Ruiz A Dermatol Ther; 2013; 26(5):415-8. PubMed ID: 24099073 [TBL] [Abstract][Full Text] [Related]
4. Magnetic resonance imaging findings are useful for evaluating the three-dimensional development and follow-up of linear lupus erythematosus profundus. Ogawa M; Muro Y; Sugiura K; Sakakibara A; Akiyama M Lupus; 2015 Oct; 24(11):1214-6. PubMed ID: 25716419 [TBL] [Abstract][Full Text] [Related]
5. A case of "refractory" lupus erythematosus profundus responsive to rituximab [case report]. McArdle A; Baker JF Clin Rheumatol; 2009 Jun; 28(6):745-6. PubMed ID: 19343472 [TBL] [Abstract][Full Text] [Related]
8. [Lupus erythematosus panniculitis: clinical and histopathological analysis of 22 cases]. Wang T; Li X; Liu YH; Zheng HY; Sun QN; Jin HZ; Ma DL; Qu T; Fang K Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2011 Oct; 33(5):525-8. PubMed ID: 22338136 [TBL] [Abstract][Full Text] [Related]